Dulla Naveen Kumar

660 citations
25 papers · 483 indexed · h-index 12

Dulla Naveen Kumar

24 papers receiving 479 citations

Peers

Dulla Naveen Kumar
Comparison fields: 5 of 82
  • Molecular Biology 271
  • Biomaterials 131
  • Biomedical Engineering 114
  • Cancer Research 105
  • Oncology 52
Replace Aiswarya Chaudhuri with:
Aiswarya Chaudhuri India
Bindu Thapa Canada
Ahmed M. E. Abdalla China
Wenhui Tao China
Maha Ali Alghamdi Saudi Arabia
Amit Singh United States
Beatriz García-Pinel Spain
Qiaoling Zhu China
Sei Yonezawa Japan
Qi Zheng China
Dulla Naveen Kumar relative to Aiswarya Chaudhuri India Aiswarya Chaudhuri's profile →
Citations per field
00.5×1.5×
Aiswarya Chaudhuri · 1×
Citations per year

Countries citing papers authored by Dulla Naveen Kumar

Since Specialization
Citations

This map shows the geographic impact of Dulla Naveen Kumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dulla Naveen Kumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dulla Naveen Kumar more than expected).

Fields of papers citing papers by Dulla Naveen Kumar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dulla Naveen Kumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dulla Naveen Kumar. The network helps show where Dulla Naveen Kumar may publish in the future.

Co-authorship network of co-authors of Dulla Naveen Kumar

This figure shows the co-authorship network connecting the top 25 collaborators of Dulla Naveen Kumar. A scholar is included among the top collaborators of Dulla Naveen Kumar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dulla Naveen Kumar. Dulla Naveen Kumar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 5
2 5
3 12
4 6
5 17
6 0
7 6
8 8
9 21
10 22
11 8
12 32
13 11
14 9
15 10
16 22
17 55
18 32
19 66
20 15

About Dulla Naveen Kumar

Dulla Naveen Kumar is a scholar working on Molecular Medicine, Pharmaceutical Science and Biomaterials, having authored 25 papers that have together received 483 indexed citations. Recurring topics across this work include Extracellular vesicles in disease (7 papers), RNA Interference and Gene Delivery (6 papers) and Nanoparticle-Based Drug Delivery (5 papers). The work is most often cited by research in Biomaterials (131 citations), Pharmaceutical Science (47 citations) and Cancer Research (105 citations). Dulla Naveen Kumar has collaborated with scholars based in India, Canada and United States. Frequent co-authors include Ashish Kumar Agrawal, Aiswarya Chaudhuri, Sanjay Singh, Deepa Dehari, Dinesh Kumar, Ramesh C. Gupta, Farrukh Aqil, Radha Munagala, Aftab Ahmad and Ashraf B. Abdel‐Naim. Their work appears in journals such as Biochemical and Biophysical Research Communications, International Journal of Molecular Sciences and International Journal of Biological Macromolecules.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026